Galderma S.A.
Galderma S.A., a leading global dermatology company headquartered in Switzerland (CH), has been at the forefront of skin health since its establishment in 1981. With a strong presence in major operational regions including Europe, North America, and Asia, Galderma focuses on innovative solutions in dermatology, offering a diverse portfolio that encompasses prescription products, aesthetic treatments, and consumer skin care. Renowned for its flagship brands such as Restylane and Cetaphil, Galderma distinguishes itself through a commitment to scientific research and development, ensuring high-quality, effective products tailored to various skin concerns. The company has achieved significant milestones, including numerous regulatory approvals and a robust market position, making it a trusted name in the dermatological field. With a dedication to enhancing skin health, Galderma continues to lead advancements in dermatological care worldwide.
DitchCarbon Score
How does Galderma S.A.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Galderma S.A.'s score of 35 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Galderma S.A., headquartered in Switzerland (CH), currently does not have publicly available carbon emissions data for the most recent year. As a current subsidiary of Galderma Group AG, any emissions data would be inherited from this parent organisation. However, there are no specific reduction targets or climate commitments outlined in the available information. Galderma S.A. has not disclosed any significant climate initiatives or pledges, such as those associated with the Science Based Targets initiative (SBTi) or other industry-standard frameworks. The absence of emissions data and reduction targets suggests that the company may still be in the early stages of formalising its climate strategy. In summary, while Galderma S.A. is part of a larger corporate structure, it currently lacks specific emissions data and defined climate commitments, reflecting a potential area for future development in sustainability practices.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | - | 0,000,000 |
| Scope 2 | 5,600,000 | 0,000,000 |
| Scope 3 | - | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Galderma S.A. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
